Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

Home Knowledge Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

To evaluate the ef­ficacy and safety under ­field conditions of the new vaccine UBAC® (HIPRA) through a multicenter, randomized, double blinded and placebo-controlled clinical trial.

About this article

Appeared in

National Mastitis Council, 2018

Date

Jun 11, 2018

Authors

Puig, A.; Perozo, E.; Roura, F.; Armengol, R.; Ponté, D.; Mallo, J.; Echevarria, J.M.; Arrieta, C.; Herrera, D.; Franquesa, O.; Urtado, L.; Calm, I.; Collado, R.; Prenafeta, T.; March, R.; Sabaté, D.

Summary

Incidence of animals with S. uberis CM was significantly lower in UBAC® group than in the Placebo group (Figure 2). Also, differences between groups in terms of incidence of animals with S. uberis ScM were not statistically significant.

Related products

Share this on